Month: May 2020

Kindra: The New P&G-Backed DTC Player in the Menopause Category

The Menopause Treatment Market is projected to reach $3.3BN by 2023, posting 4.2% CAGR from 2017 to 2023, according to MRFR. Destigmatizing menopause and capturing this opportunity has gone beyond indie trailblazers like Pause. There’s a new player in the burgeoning menopause category, launched by P&G Ventures and venture engine M13. Kindra is a direct-to-consumer brand that takes Read more…

Custom-compounded bioidentical HT for menopause symptoms may yield ‘abnormally high’ hormone levels

Pellet hormone therapy, a solid custom-compounded bioidentical estrogen therapy that is inserted under the skin, may be less safe than FDA-approved HT therapies for postmenopausal women, according to findings presented at the North American Menopause Society annual meeting. Xuezhi (Daniel) Jiang Researchers found substantially increased serum estradiol and total testosterone levels associated with pellet HT. Read more…

Could Menopause Be Disrupting Your Sleep?

The hormonal fluctuations that occur during menopause can lead to a variety of symptoms, the most common of which are hot flashes and weight gain. The biological transition that happens during menopausal years, however, can challenge a woman’s ability to sleep soundly through the night. In order to help restore a healthy sleep cycle, a woman has to understand how Read more…